catechin has been researched along with natriuretic peptide, brain in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, DD; Dong, YG; He, JG; Liu, D | 1 |
| Ceballos, G; Ciaraldi, TP; Henry, RR; Hogan, M; Maisel, AS; Murphy, AN; Naviaux, R; Perkins, G; Ramirez-Sanchez, I; Taub, PR; Villarreal, F | 1 |
| Canto, P; Coral-Vázquez, RM; De Los Santos, S; Palma-Flores, C; Zentella-Dehesa, A | 1 |
| Hu, Y; Li, J; Li, S; Li, Y; Ma, Y; Wen, J; Wu, J; Zhang, J; Zhang, L | 1 |
| Han, X; Huang, L; Luo, X; Mao, Q; Peng, C; Wu, S; Zhang, H | 1 |
5 other study(ies) available for catechin and natriuretic peptide, brain
| Article | Year |
|---|---|
Epigallocatechin-3-gallate attenuates cardiac hypertrophy in hypertensive rats in part by modulation of mitogen-activated protein kinase signals.
Topics: Animals; Antioxidants; Atrial Natriuretic Factor; Catalase; Catechin; Disease Models, Animal; DNA, Mitochondrial; Electron Transport Chain Complex Proteins; Enzyme Activation; Glutathione Peroxidase; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Malondialdehyde; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mitochondria, Heart; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Myocardium; Myosin Heavy Chains; Natriuretic Peptide, Brain; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Transcription Factor AP-1 | 2009 |
Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoa.
Topics: Aged; Beverages; Biomarkers; Biopsy; Cacao; California; Candy; Catechin; Diabetes Mellitus, Type 2; Functional Food; Glycated Hemoglobin; Heart Failure; Humans; Lipids; Middle Aged; Mitochondria, Muscle; Mitochondrial Proteins; Natriuretic Peptide, Brain; Quadriceps Muscle; Time Factors; Treatment Outcome | 2012 |
(-)-Epicatechin inhibits development of dilated cardiomyopathy in δ sarcoglycan null mouse.
Topics: Animals; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Catechin; Coronary Vessels; Disease Models, Animal; Fibrosis; Male; Mice, Knockout; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Sarcoglycans; Signal Transduction; TOR Serine-Threonine Kinases; Vasoconstriction; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Epigallocatechin-3-gallate inhibits angiotensin II-induced cardiomyocyte hypertrophy via regulating Hippo signaling pathway in H9c2 rat cardiomyocytes.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Cardiomegaly; Catechin; Cell Line; Gene Expression Regulation; Molecular Structure; Myocytes, Cardiac; Natriuretic Peptide, Brain; Protein Serine-Threonine Kinases; Rats; Reactive Oxygen Species; Signal Transduction | 2019 |
EGCG prevents pressure overload‑induced myocardial remodeling by downregulating overexpression of HDAC5 in mice.
Topics: Acetylation; Animals; Atrial Natriuretic Factor; Atrial Remodeling; Catechin; Constriction; Disease Models, Animal; Electrocardiography; Heart Failure; Histone Deacetylases; Histones; Lysine; Male; MEF2 Transcription Factors; Natriuretic Peptide, Brain; Survival Rate; Ventricular Remodeling | 2022 |